Αποτελέσματα Αναζήτησης
Evidence-based strategy document for COPD diagnosis, management, and prevention, with citations from the scientific literature. View 2023 Executive Summaries, including a podcast discussion between Dr. Alvar Agusti and ERJ regarding the new changes.
- 2023 Executive Summaries
A Summary of changes to the 2023 GOLD Report has been...
- About Us
The Latest. 2024 GOLD Conference - Registration is Open!...
- 2023 Executive Summaries
This includes indications for bullectomy or lung reduction surgery; bronchoscopic treatments for lung reduction, an evolving field both in and outside the US; and interventional treatments that are currently being studied for chronic bronchitis.
20 Ιουλ 2023 · The most recent (2023) GOLD Report has several updates relevant to COPD treatment, including updated definitions of COPD, recent associations of inhaled pharmacological therapy with mortality, expanded discussion related to inhaled drug delivery and adherence to inhaled medication, and updated recommendations for initial and follow-up ...
30 Νοε 2022 · GOLD COPD report: 2023 update. On Nov 14, 2022, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) published their 2023 global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD).
18 Μαρ 2024 · Arguably the most buzzed about advancement in the COPD treatment landscape is the emergence of new biologic therapies, says Dr. Meilan Han, a professor of medicine in the Division of Pulmonary...
12 Φεβ 2021 · The graphs represent cross-sectional data from several individuals measured at different time points. Although the rate of loss of FEV 1 for a susceptible smoker is shown, others may experience different rates of loss, and reach “disability” at different ages.
20 Ιουλ 2023 · The trend over recent GOLD reports of increasing attention to inhaler device choice is evident in the 2023 Report, which states that strength and dexterity are needed to actuate pressurized metered-dose inhalers (pMDIs), load dry powder inhalers (DPIs), and prime breath-actuated inhalers (BAIs).
